Key result
Pulmonary vein isolation resulted in 67% of patients with Brugada syndrome and paroxysmal atrial fibrillation remaining free of AF without antiarrhythmic drugs at a mean follow-up of 22.1 months.
Why the study?
Does pulmonary vein isolation prevent atrial fibrillation recurrence and inappropriate ICD shocks in patients with Brugada syndrome and drug-resistant paroxysmal atrial fibrillation?
Observational (n=9)
Does pulmonary vein isolation prevent atrial fibrillation recurrence and inappropriate ICD shocks in patients with Brugada syndrome and drug-resistant paroxysmal atrial fibrillation?
Pulmonary vein isolation appears to be an effective and safe strategy to prevent atrial fibrillation recurrence and inappropriate ICD shocks in patients with Brugada syndrome.
Answers are grounded in this paper and cite their sources.
PVI may offer a viable AF option in Brugada syndrome; leaves open need for randomized trials before practice change.
AIMS: Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada syndrome (BS) might be challenging as many antiarrhythmic drugs (AADs) with sodium channel blocking properties might expose the patients to the development of ventricular arrhythmias. Moreover, patients with BS and implantable cardioverter-defibrillator (ICD) might experience inappropriate shocks because of AF with rapid ventricular response. The role of pulmonary vein isolation (PVI) in patients with BS and recurrent episodes of AF has not been established yet. In this study, we analysed the outcome of PVI using radiofrequency energy or cryoballoon (CB) ablation at 2 years follow-up. METHODS AND RESULTS: Consecutive patients with BS having undergone PVI for drug-resistant paroxysmal AF were eligible for this study. Nine patients (three males; mean age: 52 ± 26 years) were included. Six patients (67%) had an ICD implanted of whom three had inappropriate shocks because of rapid AF. At a mean 22.1 ± 6.4 months follow-up, six patients (67%) were free of AF without AADs. None of the three patients who had experienced inappropriate ICD interventions for AF had further ICD shocks after ablation. CONCLUSION: In our study PVI can be an effective and safe procedure to treat patients with BS and recurrent episodes of paroxysmal AF.
No takes yet. Share an insight, caveat, or question.
Conte et al. (2013) conducted an observational in Brugada syndrome and paroxysmal atrial fibrillation (n=9). Pulmonary vein isolation (PVI) was evaluated on Freedom from atrial fibrillation without antiarrhythmic drugs. Pulmonary vein isolation resulted in 67% of patients with Brugada syndrome and paroxysmal atrial fibrillation remaining free of AF without antiarrhythmic drugs at a mean follow-up of 22.1 months.
Synapse has enriched 10 related papers. Consider them for comparative context: